For the Very First Time: FDA Clears New Sacroiliac Joint Fusion Screws For Use With Alternate Posterior Approach on April 24th, 2015

Share Article

On April 24th, 2015, SpineFrontier officially received FDA clearance to begin manufacturing and distributing their new Sacroiliac Joint Fusion (SIJ Fuse) system, which is 510k cleared for an alternate posterior surgical approach.

40mm SIJFuse Screw

40mm SIJFuse Screw

The flexibility that this system and surgical approach brings to surgeons is very important.

SpineFrontier, a Less Exposure Surgery (LES) technology company, has received clearance from the FDA to produce and market their new sacroiliac joint fusion screw, the SIJ Fuse. This device can be used in outpatient settings and is compatible with both lateral and alternate posterior approaches.

The alternate posterior approach has been extensively researched and refined by SpineFrontier, the first company to attain a 510k approval to use this approach in conjunction with a sacroiliac joint fusion system like this. The approach and trajectory minimizes tissue disruption and nerve injury, and maximizes bone fixation in comparison with the traditional approach. This promotes a fast, comfortable patient recovery.

“We are very excited to release our new SIJFuse screw system. The flexibility that this system and surgical approach brings to surgeons is very important. This screw system, paired with the alternate posterior approach is another example of our commitment to continue pioneering the future of spine surgery,” says Mark Foley, Mechanical Engineer at SpineFrontier.

The SIJFuse system is offered in solid and hollow-cored (fenestrated) models. It will be available for order later this year.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Anders Johnson
SpineFrontier

Visit website